FDA Inspection 1226714 — Somerset Therapeutics Private Limited

Somerset Therapeutics Private Limited — FEI 3003821988

The FDA completed an inspection of Somerset Therapeutics Private Limited on October 27, 2023 in Bengaluru. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 27, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bengaluru (India)